Bad cholesterol slashed 62% by single dose of gene-editing drug in small trial | Noticias Tech y Ciencia Actualizadas

Bad cholesterol slashed 62% by single dose of gene-editing drug in small trial The interim Phase I trial data was only from 35 people, but results look good so far. … Leer más